Full name
BIOGENE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73 - Retail sale of pharmaceutical products
47.74 - Retail sale of medical and orthopedic products
72 - Scientific research and development activities
73 - Advertising, market research and public relations
77 - Rental and leasing
85 - Education
86 - Healthcare
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | -0,2 | 0,3 | 259,9 |
EBITDA | -0,2 | 0,1 | 0,5 | 253,5 |
Short time liabilities | 1,1 | 0,9 | 0,8 | -6,7 |
Equity capital | -0,3 | -0,3 | -0,1 | 83,3 |
Operating profit (EBIT) | -0,3 | 0 | 0,3 | 2473,8 |
Assets | 1 | 1,1 | 1,1 | -0,7 |
Net profit (loss) | -0,3 | -0,2 | 0,3 | 248,1 |
Cash | 0 | 0,2 | 0,1 | -70,5 |
Net income from sale | 4 | 3,4 | 4,6 | 37,4 |
Liabilities and provisions for liabilities | 1,3 | 1,4 | 1,2 | -20,1 |
Working assets | 0,3 | 0,4 | 0,4 | -10,7 |
Depreciation | 0,1 | 0,1 | 0,1 | 23,5 |
% | % | % | p.p. | |
Profitability of capital | 101,4 | 56,2 | -497,5 | -553,7 |
Equity capital to total assets | -33,4 | -30,7 | -5,2 | 25,5 |
Gross profit margin | -8 | -5,7 | 6,6 | 12,3 |
EBITDA Margin | -5,5 | 4 | 10,2 | 6,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 103 | 95 | 64 | -31 |
Current financial liquidity indicator | 0.2794513702392578 | 0.4674854874610901 | 0.44757676124572754 | -0,1 |
Net dept to EBITDA | -1.9742417335510254 | 5.546012878417969 | 1.0816541910171509 | -4,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane